Literature DB >> 12702964

Defining the pathologic diagnosis of metaplasia, atrophy, dysplasia, and gastric adenocarcinoma.

Gregory Y Lauwers1.   

Abstract

Epidemiologic and pathologic studies have confirmed that the development of gastric cancer spans over several decades starting with Helicobacter pylori chronic active gastritis followed, over time and only in a subset of patients, with the development of intestinal metaplasia and atrophy, dysplasia, and finally gastric adenocarcinoma. It has also been established that the pathogenesis of gastric cancer is a multifactorial process in which both environmental and host-related factors play significant role. Improvement in upper endoscopic techniques make possible the detection of not only early gastric cancers but also the mucosal alterations that predate malignant degeneration. A better understanding of the gastric carcinogenic sequence will allow us to better identify the patients at risk and to implement preventive strategies. We review the histopathologic steps that predate the development of gastric cancer and evaluate the risks of transformation that they confer.

Entities:  

Mesh:

Year:  2003        PMID: 12702964     DOI: 10.1097/00004836-200305001-00007

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  14 in total

1.  Magnifying endoscopy of gastric epithelial dysplasia based on the morphologic characteristics.

Authors:  Hwa Mi Kang; Gwang Ha Kim; Do Youn Park; Hong Ryeol Cheong; Dong Hoon Baek; Bong Eun Lee; Geun Am Song
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

2.  Gastric cancer precursor lesions and Helicobacter pylori infection in patients with partial gastrectomy for peptic ulcer.

Authors:  Andrea Giuliani; Alessandro Caporale; Martino Demoro; Eugenio Benvenuto; Massimo Scarpini; Sebastiano Spada; Francesco Angelico
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

3.  Intestinal metaplasia of the sinonasal mucosa adjacent to intestinal-type adenocarcinoma. A morphologic, immunohistochemical, and molecular study.

Authors:  Alessandro Franchi; Annarita Palomba; Lucia Miligi; Valentina Ranucci; Duccio Rossi Degli Innocenti; Antonella Simoni; Monica Pepi; Marco Santucci
Journal:  Virchows Arch       Date:  2014-11-28       Impact factor: 4.064

Review 4.  Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications.

Authors:  Keishi Yamashita; Shinichi Sakuramoto; Masahiko Watanabe
Journal:  Surg Today       Date:  2010-12-30       Impact factor: 2.549

5.  Low Levels of Pepsinogen I and Pepsinogen I/II Ratio are Valuable Serologic Markers for Predicting Extensive Gastric Corpus Atrophy in Patients Undergoing Endoscopic Mucosectomy.

Authors:  Ho June Song; Se Jin Jang; Sung-Cheol Yun; Young Soo Park; Mi-Jung Kim; Sun-Mi Lee; Kee Don Choi; Gin Hyug Lee; Hwoon-Yong Jung; Jin-Ho Kim
Journal:  Gut Liver       Date:  2010-12-17       Impact factor: 4.519

6.  Impact of diet on long-term decline in gastric cancer incidence in Poland.

Authors:  Mirosław Jarosz; Włodzimierz Sekuła; Ewa Rychlik; Katarzyna Figurska
Journal:  World J Gastroenterol       Date:  2011-01-07       Impact factor: 5.742

7.  Ectopic expression of guanylyl cyclase C and endogenous ligand guanylin correlates significantly with Helicobacter pylori infection in gastric carcinogenesis.

Authors:  Jian-Feng Zhang; Zhen-Biao Mao; Zeng-Li Li; Shi-Min Xue; Hui-Jun Zhu; Hong Zhang; Run-Zhou Ni
Journal:  Med Oncol       Date:  2011-10-05       Impact factor: 3.064

8.  Loss of FHIT expression in gastric mucosa of patients with family histories of gastric cancer and Helicobacter pylori infection.

Authors:  Krystyna Stec-Michalska; Slawomir Antoszczyk; Grazyna Klupinska; Barbara Nawrot
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

9.  British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.

Authors:  Matthew Banks; David Graham; Marnix Jansen; Takuji Gotoda; Sergio Coda; Massimiliano di Pietro; Noriya Uedo; Pradeep Bhandari; D Mark Pritchard; Ernst J Kuipers; Manuel Rodriguez-Justo; Marco R Novelli; Krish Ragunath; Neil Shepherd; Mario Dinis-Ribeiro
Journal:  Gut       Date:  2019-07-05       Impact factor: 23.059

10.  Caveolin-1, E-cadherin and β-catenin in Gastric Carcinoma, Precancerous Tissues and Chronic Non-atrophic Gastritis.

Authors:  Guo-Yang Sun; Jun-Xia Wu; Jian-Sheng Wu; Yu-Ting Pan; Rong Jin
Journal:  Chin J Cancer Res       Date:  2012-03       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.